Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV Infection
Clinical trial NCT02981602 · COMPLETED
Trial details
- NCT number
- NCT02981602
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-24
- Primary completion
- 2019-12-18
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.